Until targeted gene-specific therapies become widely available and effective for all MC4R variants, GLP-1 RAs represent a crucial therapeutic tool, offering a path toward significant clinical benefit for patients grappling with this challenging form of monogenic obesity
Christian also has expertise in treating children, adolescents, teens, and adults who suffer from chronic illness
Scientists found that a natural gut hormone, glucagon-like peptide-1 (GLP-1), helps control blood sugar by stimulating insulin, slowing digestion, and signaling fullness to the brain
GLP-1 medications are emerging as an evidence-based approach to weight loss and metabolic health, and soon patients will be able to access this care conveniently through telehealth with Oregon Telemed
Systematic reviews examining this intervention have reported that patients treated with GLP-1 receptor agonists after bariatric surgery achieved an average additional weight loss of 510% of total body weight over 612 months, though results vary considerably by individual, procedure type, and specific medication used
Patients on tirzepatide often experience reduced appetite and may inadvertently consume insufficient calories or essential nutrients
